Regarding associations with health outcomes, we observed slightly more significant p-values, such as the effects of PCPhenoAgeEAA on T2D, hypertension, AST, ALT, and FVC% PRED in the KARE cohort (Figure 2; Supplementary Table S11). This evidence concerns the gene GPT and type 2 diabetes mellitus.